BrightSpring Health Services, Inc. BTSG
BrightSpring Health Services, Inc. (BTSG) earns a Piotroski F-score of 7/9 (strong financial health), with an Altman Z″ in the grey zone. It does not currently pay a dividend. FY2025 revenue was $12.9B at a 1.5% net margin.
Quality score trend · recomputed for each fiscal year
Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.
Beneish M-score: -2.57 — low (below −2.22 — no manipulation red flag) . A statistical screen for earnings manipulation, not proof — and it doesn't apply to most banks/insurers.
Analyst price target
Recent analyst actions
| Date | Firm | Rating |
|---|---|---|
| 2026-08-03 | BTIG | Buy (reit) |
| 2026-07-14 | Morgan Stanley | Overweight (main) |
| 2026-07-14 | Keybanc | Overweight (main) |
| 2026-07-13 | Wells Fargo | Overweight (main) |
| 2026-07-13 | Guggenheim | Buy (init) |
| 2026-07-10 | Raymond James | Outperform (init) |
Wall Street analyst consensus — a sentiment gauge, not our scoring.
Forward estimates · earnings calendar →
Consensus analyst estimates and scheduled dates — forward-looking, may change.
How it ranks in Services · percentile among 982 companies
Percentile vs other Services companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 7/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″ components · grey zone
| Component | Value |
|---|---|
| Working capital / assets | 0.163 |
| Retained earnings / assets | -0.012 |
| EBIT / assets | 0.046 |
| Equity / liabilities | 0.414 |
Sector peers · similar-size Services companies compare side by side →
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| BTSG | BrightSpring Health Services, Inc. | 7/9 | 1.78 | 71 | +28.2% |
| OPCH | Option Care Health, Inc. | 5/9 | 2.97 | 16.5 | +13% |
| AHCO | AdaptHealth Corp. | 5/9 | 0.26 | — | -0.5% |
| CHE | CHEMED CORP | 5/9 | 9.65 | 23.2 | +4.1% |
| AVAH | Aveanna Healthcare Holdings, Inc. | 6/9 | -0.46 | 8.4 | +20.2% |
| ADUS | Addus HomeCare Corp | 7/9 | 5.5 | 18.9 | +23.2% |
| EDGM | Edgemode, Inc. | 3/9 | — | — | — |
About BrightSpring Health Services, Inc.
BrightSpring Health Services, Inc. operates as a home and community-based healthcare services platform in the United States. The company operates through two segments, Pharmacy Solutions and Provider Services. Its platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations. It also offers infused, injectable, and oral medication services; and patient-centric, highly skilled, and compassionate clinical home health care, as well as rehabilitation services, including physical, speech and occupational therapy and applied behavioral analysis. The company was formerly known as Phoenix Parent Holdings Inc. and changed its name to BrightSpring Health Services, Inc. in May 2021. BrightSpring Health Services, Inc. was founded in 1974 and is headquartered in Louisville, Kentucky.
FAQ
Is BTSG financially healthy?
BrightSpring Health Services, Inc.'s Piotroski F-score is 7/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the grey zone.
Does BTSG pay a dividend?
No, BrightSpring Health Services, Inc. does not currently pay a dividend.
How profitable is BTSG?
In FY2025, BrightSpring Health Services, Inc. had a net margin of 1.5% and a return on equity of 10.2%.
What is BTSG's P/E ratio?
BrightSpring Health Services, Inc.'s trailing price-to-earnings (P/E) ratio is about 71.0×, based on its latest annual earnings.
What is the analyst price target for BTSG?
The average Wall-Street price target for BrightSpring Health Services, Inc. is $78.94, about 32.3% above the recent price, from 17 analysts (consensus: strong buy).
Is BTSG a good stock to buy?
Stocktoria doesn't give buy or sell advice, but here is the data on BrightSpring Health Services, Inc.: a Piotroski F-score of 7/9, an Altman Z″ in the grey zone, a P/E of about 71.0×. Weigh these quality and valuation signals against your own goals.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.